You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 12, 2024

PROMETH PLAIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Prometh Plain, and what generic alternatives are available?

Prometh Plain is a drug marketed by Actavis Mid Atlantic and is included in one NDA.

The generic ingredient in PROMETH PLAIN is promethazine hydrochloride. There are twelve drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Prometh Plain

A generic version of PROMETH PLAIN was approved as promethazine hydrochloride by ZYDUS PHARMS USA on November 18th, 2005.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PROMETH PLAIN?
  • What are the global sales for PROMETH PLAIN?
  • What is Average Wholesale Price for PROMETH PLAIN?
Summary for PROMETH PLAIN
Drug patent expirations by year for PROMETH PLAIN
Recent Clinical Trials for PROMETH PLAIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
M.D. Anderson Cancer CenterN/A

See all PROMETH PLAIN clinical trials

US Patents and Regulatory Information for PROMETH PLAIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic PROMETH PLAIN promethazine hydrochloride SYRUP;ORAL 085953-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.